HR0716LRB101 20252 MST 69792 r


  
1
HOUSE RESOLUTION

  
 
2    WHEREAS, Cholangiocarcinoma (bile duct cancer) is a rare 
3form of cancer that originates
from the cells lining the bile 
4ducts that play a key role in digestion; there are three types, 
5Intrahepatic,
extrahepatic, and perihilar; and
  
 
6    WHEREAS, There are approximately 12,000 Americans 
7diagnosed each year in the United States,  with numbers

8increasing yearly; the mortality rate has increased 
9dramatically in the last decade; and
  
 
10    WHEREAS, Patients are typically diagnosed at a late stage 
11due to no validated early method of detection; symptoms of 
12jaundice, abdominal pain, itchy skin, and weight loss are 
13symptoms that do not usually present till
advanced disease 
14progression; and
  
 
15    WHEREAS, Cholangiocarcinoma is a rare cancer; of the top 
16eight deadliest cancers, seven  are rare; rare cancers
have a 
17five-year survival rate under 50%, with the cholangiocarcinoma 
18five-year survival rate being approximately
20%; and
 
19    WHEREAS, There is currently no cure for 
20cholangiocarcinoma/bile duct cancer; and
 
 
 
HR0716- 2 -LRB101 20252 MST 69792 r

1    WHEREAS, Kelly green  is the color representing 
2cholangiocarcinoma/bile duct cancer awareness; and
  
 
3    WHEREAS, Foundations, research and teaching hospitals, 
4rare cancer advocate groups, and patient
advocate groups from 
5around the globe have joined together  to recognize February 12, 
62020 as World Cholangiocarcinoma Day; and
  
 
7    WHEREAS, Increased cholangiocarcinoma advocacy, awareness, 
8research, and education will bring
improved outcomes for 
9patients in earlier detection and treatment and potential 
10curative methods; therefore, be it
  
 
11    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE 
12HUNDRED FIRST GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that 
13we recognize February 12, 2020 as being World 
14Cholangiocarcinoma Day.